Amarin Pharma Inc. v. International Trade Commission
Petition for certiorari denied on December 9, 2019
Issue: Whether, when a manufacturer files a Lanham Act claim under the Tariff Act for competitive injuries caused by unfair trade practices, the claim is barred as a matter of law when the International Trade Commission would need to consider the meaning of terms used in the Food, Drug and Cosmetic Act in
order to determine whether the claim has merit.
Date | Proceedings and Orders (key to color coding) |
---|
Jul 30 2019 | Petition for a writ of certiorari filed. (Response due September 3, 2019) |
Aug 27 2019 | Motion of International Trade Commission, et al. for an extension of time not accepted for filing. (August 28, 2019 - Corrected motion to be filed) |
Aug 28 2019 | Motion to extend the time to file a response from September 3, 2019 to October 3, 2019, submitted to The Clerk. |
Aug 30 2019 | Motion to extend the time to file a response is granted and the time is extended to and including October 3, 2019, for all respondents. |
Sep 30 2019 | Motion to extend the time to file a response from October 3, 2019 to November 4, 2019, submitted to The Clerk. |
Oct 02 2019 | Motion to extend the time to file a response is granted and the time is further extended to and including November 4, 2019, for all respondents. |
Oct 22 2019 | Letter of October 22, 2019 from counsel for petitioners filed. |
Nov 04 2019 | Brief of respondents International Trade Commission, et al. in opposition filed. |
Nov 04 2019 | Brief of respondents Royal DSM NV, et al. in opposition filed. |
Nov 18 2019 | Reply of petitioners Amarin Pharma, Inc., et al. filed. |
Nov 20 2019 | DISTRIBUTED for Conference of 12/6/2019. |
Dec 09 2019 | Petition DENIED. |